Botswana - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Botswana Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 15.4% year on year. With 84 Cases in 2019, the country was number 150 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India topped the ranking with 66,255 Cases in 2019, an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 84.00 |
| 2018 | 85.00 |
| 2017 | 87.00 |
| 2016 | 104.00 |
| 2015 | 57.00 |
Download all data from 2007 to 2019
How does Botswana rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 148 |
#148
France
|
86 | 2019 | +3.6 % | -5.0 % | View data | |
| 150 |
#150
Botswana
|
84 | 2019 | -1.2 % | +15.4 % | View data | |
| 152 |
#152
Japan
|
83 | 2019 | +0.0 % | +0.5 % | View data | |